CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 4 Open-market sale Director sold 42,000 shares at $67.41 ($2,831,388)
- 424B5 Offering Prospectus
- 4 Open-market sale President sold 33,618 shares at $70.00 ($2,353,260)
- 4 Open-market sale Director sold 7,500 shares at $62.00 ($465,000)
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Director sold 7,500 shares at $55.00 ($412,500)
- 4 Open-market sale Director sold 7,500 shares at $52.00 ($390,000)
- 4 Open-market sale Director sold 21,000 shares at $51.89 ($1,089,675)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 28 of 45 · 883 filings